Industries
Two flagship sectors. Six more in active advisory.
Sector knowledge decides the answer. A margin problem in a hospital is not a margin problem in a restaurant, and the fix does not transfer. Healthcare and life sciences lead our practice. Pharma and biologics run alongside it. Six further sectors are in active advisory and get full pages in the next phase.
Flagship
Healthcare & Life Sciences
We work hospitals, clinics, and diagnostic networks through the decisions that carry consequence: margin recovery, entry at scale, operational turnaround, capacity, and M&A that has to close right the first time.
Read the sectorCo-flagship
Pharma & Biologics
We move products to GCC patients faster, decide manufacturing localisation, set biologics strategy, and advise pharma M&A across the region.
Read the sectorIn active advisory
Six sectors we work now.
Dedicated pages follow in the next phase. The work is not new to us.
Technology & Fintech
Market entry, capital raises, and licensing for platforms scaling into the GCC.
Energy & Infrastructure
Strategy, transactions, and PPP advisory for large-capital projects.
Logistics & Supply Chain
Network economics, corridor risk, and operational performance.
Hospitality & F&B
Feasibility, franchise structuring, and unit economics for GCC operators.
Consumer & Retail
Entry strategy, format economics, and M&A for consumer brands.
Defence
Strategy and market-access advisory for a governed, relationship-led sector.
If your sector is not yet a full page, the work is not new to us. Start with a conversation.